High-dose GLP-1 RA use is associated with a significantly lower risk for hepatic encephalopathy and mortality in cirrhosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results